Expert warns of limitations of new MCI, Alzheimer's criteria

02/6/2012 | MolecularImaging.net

The revised criteria for the diagnosis of mild cognitive impairment, as determined by the National Institute on Aging and the Alzheimer's Association last year, are too broad in terms of what constitutes functional independence and "thus blur the categorical distinction between MCI and dementia," Dr. John C. Morris from Washington University in St. Louis wrote in an analysis published in Archives of Neurology. Morris expressed concern that the guidelines would compromise the diagnosis of Alzheimer's disease dementia. "It is now time to advance AD patient care and research by accepting that 'MCI due to AD' is more appropriately recognized as the earliest symptomatic stage of AD," he wrote.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC